Cargando…
Emerging Drug Targets for Endometriosis
Endometriosis is a chronic inflammatory disease causing distressing symptoms and requiring a life-long management strategy. The objective of this review is to evaluate endometriosis-related pathways and identify novel therapies to treat it. We focused on the crucial role of inflammation and inflamma...
Autores principales: | Dolmans, Marie-Madeleine, Donnez, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687824/ https://www.ncbi.nlm.nih.gov/pubmed/36359004 http://dx.doi.org/10.3390/biom12111654 |
Ejemplares similares
-
Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?
por: Cacciottola, Luciana, et al.
Publicado: (2021) -
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021) -
GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?
por: Donnez, Jacques, et al.
Publicado: (2021) -
Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review
por: Donnez, Jacques, et al.
Publicado: (2023) -
Uterine fibroid management: from the present to the future
por: Donnez, Jacques, et al.
Publicado: (2016)